Protalix BioTherapeutics, Inc. Common Stock (AMEX: PLX) last traded at $2.38, up 0.00% on the session. The quote above updates while this page is open; the figures below are drawn from Protalix BioTherapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Protalix BioTherapeutics, Inc. Common Stock trades on AMEX under the ticker PLX. Its market capitalisation is $191.76 million.
Valuation measures for Protalix BioTherapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $191.76M |
|---|---|
| Enterprise value | $203.27M |
| P/E ratio | 9.92 |
| Price / sales | 2.38 |
| Price / book | 2.69 |
| Beta | 1.27 |
Trailing-twelve-month figures tagged in Protalix BioTherapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $80.62M |
|---|---|
| Net income (TTM) | $18.95M |
| EPS (TTM) | $0.240 |
| Operating margin | 28.89% |
| Return on equity | 26.53% |
| Cash | $27.42M |
Range and volume for PLX over the past 52 weeks.
| 52-week high | $3.19 |
|---|---|
| 52-week low | $1.52 |
| Volume | 600.2K |
| Average volume | 678.7K |
| Previous close | $2.38 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.